Blood Res.  2013 Jun;48(2):160-163. 10.5045/br.2013.48.2.160.

Thrombocytopenia caused by low-dose heparin supplementation of parenteral nutrition solution

• Lee E
• Lee JO
• Lim Y
• Kim JY
• Kim HK
• Bang SM

• KMID: 2172920
• DOI: http://doi.org/10.5045/br.2013.48.2.160

Abstract

No abstract available.

MeSH Terms

Heparin
Parenteral Nutrition
Thrombocytopenia
Heparin

Figure

• 

  Fig. 1 Right pulmonary artery (yellow arrow) (A) and left pulmonary artery (yellow arrow) (B) occluded by PTEs.

• 

  Fig. 2 Filling defect of right distal calf vein (yellow arrow) due to thrombosis and swollen right lower leg.

• 

  Fig. 3 Near total obstruction of right popliteal vein due to extensive DVT.

• 

  Fig. 4 Decrease and recovery of platelet count with respect to the start and cessation of heparin-supplemented TPN. Abbreviations: AD, admission date; TPN, total parenteral nutrition.

Reference

1. Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e495S–e530S. PMID: 22315270.

2. Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation. 2005; 111:2671–2683. PMID: 15911718.

3. Prechel M, Walenga JM. Heparin-induced thrombocytopenia: an update. Semin Thromb Hemost. 2012; 38:483–496. PMID: 22399304.

4. Babuin L, Pengo V. Argatroban in the management of heparin-induced thrombocytopenia. Vasc Health Risk Manag. 2010; 6:813–819. PMID: 20859550.

5. Cohen RA, Castellano M, Garcia CA. Heparin induced thrombocytopenia: case presentation and review. J Clin Med Res. 2012; 4:68–72. PMID: 22383932.

6. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl):311S–337S. PMID: 15383477.

7. Kim SY, Kim HK, Han KS, et al. Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia. Korean J Lab Med. 2011; 31:1–8. PMID: 21239863.

8. Tan CW, Ward CM, Morel-Kopp MC. Evaluating heparin-induced thrombocytopenia: the old and the new. Semin Thromb Hemost. 2012; 38:135–143. PMID: 22422328.

9. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2006; 355:809–817. PMID: 16928996.

10. Kadidal VV, Mayo DJ, Horne MK. Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases. J Intern Med. 1999; 246:325–329. PMID: 10476001.

11. Vezali E, Elefsiniotis I, Pirounaki M, Boltsis N, Paizis V, Moulakakis A. Heparin-induced thrombocytopaenia due to heparin flushes: report of two cases. Int J Clin Pract. 2007; 61:516–518. PMID: 17313623.

12. Muslimani AA, Ricaurte B, Daw HA. Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes. Am J Hematol. 2007; 82:652–655. PMID: 17177192.

13. McNulty I, Katz E, Kim KY. Thrombocytopenia following heparin flush. Prog Cardiovasc Nurs. 2005; 20:143–147. PMID: 16276136.

14. Tighe MJ, Wong C, Martin IG, McMahon MJ. Do heparin, hydrocortisone, and glyceryl trinitrate influence thrombophlebitis during full intravenous nutrition via a peripheral vein? JPEN J Parenter Enteral Nutr. 1995; 19:507–509. PMID: 8748367.